68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma Comparison With 18F-FDG

被引：8

作者：

Derlin, Thorsten ^{[1
]}

Hueper, Katja ^{[2
]}

Soudah, Bisharah ^{[3
]}

机构：

[1] Hannover Med Sch, Dept Nucl Med, Carl Neuberg Str 1, D-30625 Hannover, Germany

[2] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany

[3] Hannover Med Sch, Inst Pathol, Hannover, Germany

来源：

CLINICAL NUCLEAR MEDICINE | 2017年 / 42卷 / 11期

关键词：

F-18-FDG; hemangioendothelioma; metastases; octreotide; PET/CT; somatostatin receptor;

D O I：

10.1097/RLU.0000000000001814

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Epithelioid hemangioendothelioma (EHE) is a rare tumor originating from vascular endothelial or pre-endothelial cells. It has the potential to metastasize. We present the case of a 51-year-old woman with metastasizing EHE who underwent both F-18-FDG and Ga-68-DOTA-TATE PET/CT for staging of disease and for evaluation of targeted radionuclide therapy potential. On Ga-68-DOTA-TATE PET scans, intense tracer accumulation was observed inmetastases. Besides the increased glucose metabolism in EHE, this case highlights the potential of Ga-68-DOTA-TATE PET/CT for restaging of EHE and the option of targeted radionuclide therapy in this entity.

引用

页码：E478 / E479

页数：2

共 50 条

[1] 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma
Derlin, Thorsten
Sohns, Jan M.
Hueper, Katja
CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : E210 - E211
[2] 68Ga-PSMA Versus 18F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma
Senses, Veysi
Kaplan, Ihsan
Kaya, Fulya
Ibiloglu, Ibrahim
Can, Canan
CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : e464 - e467
[3] 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Extra-adrenal Paraganglioma in a Case of Complete Carney Triad
Derlin, Thorsten
Hartung, Dagmar
Hueper, Katja
CLINICAL NUCLEAR MEDICINE, 2017, 42 (12) : E527 - E528
[4] 18F-FDG PET/CT Imaging of Prostatic Epithelioid Hemangioendothelioma
Deng, Yan
Deng, Yujiao
He, Limeng
Zhang, Wei
Lei, Xiaoping
CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 191 - 192
[5] Epithelioid hemangioendothelioma: evaluation by 18F-FDG PET/CT
Lima, Livia Maria Frota
Packard, Annie T.
Broski, Stephen M.
AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (02): : 77 - 86
[6] 68Ga-DOTA-FAPI-46 PET/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma Comparison With 68Ga-DOTA-TATE PET/CT
Sahin, Rahime
Baloglu, Mehmet Can
Ergul, Nurhan
Cermik, Tevfik Fikret
Arslan, Esra
CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : e622 - e624
[7] 68Ga-DOTA-IBA PET/CT and 18F-FDG PET/CT in Ewing Sarcoma
Xiang, Feifan
Liu, Huipan
Tan, Xiaoqi
Ma, Wenzhe
Chen, Yue
CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : 1036 - 1038
[8] Multicenter Comparison of 18F-FDG and 68Ga-DOTA-Peptide PET/CT for Pulmonary Carcinoid
Lococo, Filippo
Perotti, Germano
Cardillo, Giuseppe
De Waure, Chiara
Filice, Angelina
Graziano, Paolo
Rossi, Giulio
Sgarbi, Giorgio
Stefanelli, Antonella
Giordano, Alessandro
Granone, Pierluigi
Rindi, Guido
Versari, Annibale
Rufini, Vittoria
CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : E183 - E189
[9] Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
Cheng, Monica
Tann, Mark
HEPATOBILIARY SURGERY AND NUTRITION, 2022,
[10] 68Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT
Luo, Yaping
Cao, Xinxin
Pan, Qingqing
Li, Jian
Feng, Jun
Li, Fang
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (12) : 1724 - 1729

← 1 2 3 4 5 →